靶向CXCR4的PET/CT早期无创检测放射性肺损伤
研究合成靶向CXCR4的新型示踪剂[18F]AlF-NOTA-QHY-04,在大鼠放射性肺损伤模型中较[18F]FDG PET/CT更早检出照射肺摄取增高,并在14例放射性肺炎患者中验证其可行性,提示该示踪剂具有早期监测放射性肺损伤的临床潜力。
要点
- 在大鼠模型中,[18F]AlF-NOTA-QHY-04在放疗后第6天即见照射肺摄取显著增高,第14天达峰,而[18F]FDG在放疗后第7天和第15天未见明显摄取。
- 14例放射性肺炎患者中,照射肺SUVmax显著高于正常肺,且2级放射性肺损伤患者SUVmax显著高于1级患者。
- 微CT在放疗后42天才显示肺炎,提示[18F]AlF-NOTA-QHY-04 PET/CT可较形态学成像更早发现放射性肺损伤。
核心结论
- 研究表明[18F]AlF-NOTA-QHY-04 PET/CT在大鼠模型中可无创且较[18F]FDG PET/CT更早检测放射性肺损伤;临床研究验证了其可行性,提示其作为早期监测放射性肺损伤PET/CT示踪剂的临床潜力。
研究设计与样本
- 构建放射性肺损伤大鼠模型,放疗后定期行[18F]AlF-NOTA-QHY-04 PET/CT与[18F]FDG PET/CT扫描,并在摄取峰值日进行动态、阻断、放射自显影和組織病理学研究。
- 纳入14例在胸部放疗期间或之后发生放射性肺炎的患者,行[18F]AlF-NOTA-QHY-04 PET扫描。
主要发现
- [18F]AlF-NOTA-QHY-04的产率为28.5-43.2%,比活度为27-33 GBq/μmol,主要经肾脏排泄。
- 大鼠模型中,放疗后第6天照射肺较正常肺[18F]AlF-NOTA-QHY-04摄取显著增高,第14天达峰;放疗后第7天和第15天[18F]FDG未见明显摄取;微CT在放疗后42天才显示肺炎。
- 放射自显影证实照射肺[18F]AlF-NOTA-QHY-04摄取显著增高;免疫荧光染色显示照射肺组织CXCR4表达显著增高,与苏木精-伊红和Masson三色染色结果相关。
- 14例放射性肺炎患者中,照射肺SUVmax显著高于正常肺;2级放射性肺损伤患者SUVmax显著高于1级患者。
关键数值与推荐
- [18F]AlF-NOTA-QHY-04产率28.5-43.2%,比活度27-33 GBq/μmol。
- 大鼠模型放疗后第6天照射肺[18F]AlF-NOTA-QHY-04摄取较正常肺显著增高,第14天达峰;[18F]FDG在放疗后第7天和第15天无明显摄取;微CT放疗后42天才显示肺炎。
- 14例患者照射肺SUVmax显著高于正常肺;2级放射性肺损伤患者SUVmax显著高于1级患者。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Radiation-induced lung injury (RILI) is a severe side effect of radiotherapy (RT) for thoracic malignancies and we currently lack established methods for the early detection of RILI. In this study, we synthesized a new tracer, [18F]AlF-NOTA-QHY-04, targeting C-X-C-chemokine-receptor-type-4 (CXCR4) and investigated its feasibility to detect RILI. METHODS: An RILI rat model was constructed and scanned with [18F]AlF-NOTA-QHY-04 PET/CT and [18F]FDG PET/CT periodically after RT. Dynamic, blocking, autoradiography, and histopathological studies were performed on the day of peak uptake. Fourteen patients with radiation pneumonia, developed during or after thoracic RT, were subjected to PET scan using [18F]AlF-NOTA-QHY-04. RESULTS: The yield of [18F]AlF-NOTA-QHY-04 was 28.5-43.2%, and the specific activity was 27-33 GBq/μmol. [18F]AlF-NOTA-QHY-04 was mainly excreted through the kidney. Significant increased [18F]AlF-NOTA-QHY-04 uptake in the irradiated lung compared with that in the normal lung in the RILI model was observed on day 6 post-RT and peaked on day 14 post-RT, whereas no apparent uptake of [18F]FDG was shown on days 7 and 15 post-RT. MicroCT imaging did not show pneumonia until 42 days post-RT. Significant intense [18F]AlF-NOTA-QHY-04 uptake was confirmed by autoradiography. Immunofluorescence staining demonstrated expression of CXCR4 was significantly increased in the irradiated lung tissue, which correlated with results obtained from hematoxylin-eosin and Masson's trichrome staining. In 14 patients with radiation pneumonia, maximum standardized uptake values (SUVmax) were significantly higher in the irradiated lung compared with those in the normal lung. SUVmax of patients with grade 2 RILI was significantly higher than that of patients with grade 1 RILI. CONCLUSION: This study indicated that [18F]AlF-NOTA-QHY-04 PET/CT imaging can detect RILI non-invasively and earlier than [18F]FDG PET/CT in a rat model. Clinical studies verified its feasibility, suggesting the clinical potential of [18F]AlF-NOTA-QHY-04 as a PET/CT tracer for early monitoring of RILI.
引用
- Pei J, Cheng K, Liu T, et al. Early, non-invasive detection of radiation-induced lung injury using PET/CT by targeting CXCR4. Eur J Nucl Med Mol Imaging. 2023. PMID: 38030744. doi:10.1007/s00259-023-06517-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。